Schedule a free demo with us to get a personalised tour of
RetinoScan conducts primary eye screening for targeted ocular diseases, in the blink of an eye. Once a disease state is verified, RetinoScan Advanced determines disease severity, provides monitoring services, referral pathways and AI powered alerts within the TeleEye MD platform.
RetinoScan is TeleMedC’s AI diagnostic offering, analysing retinal images in under a minute to accurately identify whether a patient has Diabetic Retinopathy, Glaucoma and/or Age Related Macular Degeneration (ARMD).
RetinoScan is a CE, TGA, ISO, HSA and MDA (soon to be FDA) approved Class 2 medical device suitable for mass deployment.
Our mission is to improve access to eye health services worldwide, including remote and isolated communities. The early detection of chronic eye disease is vital in saving sight and lowering the lifetime costs of treatment.
The results of RetinoScan are viewed through the TeleEye MD web platform for health professionals, and mobile app for patients. Performed by TeleMedC’s retinal camera TeleEye Scan, RetinoScan's intelligent software can receive images from compatible cameras via our TeleBridge device.
For patients with a disease diagnosis, RetinoScan Advanced uses powerful AI algorithms to determine disease severity and provide lesion monitoring services. RetinoScan Advanced works within the TeleEye MD platform to provide information about the patient's disease progression.
RetinoScan Advance is initiated through telemedicine quality assurance, when Eye Care Practitioners verify results and initiate the referral pathway. Patient care is coordinated by connecting frontline health care professionals. Clinical updates are recieved via the TeleEye MD web platform to facilitate efficient communication.
The integration of care by health practitioners for each patient is highly visible. The referral pathway maintains a clear record of progress and decision making over time. AI powered alerts within the TeleEye MD platform are used to ensure timely follow up.
Sophisticated AI technology analyses retinal images in under a minute. Diagnosis is made with clinical accuracy and detailed reports provided to support clinical decision making.
Our cloud-based management platform, TeleEye MD, securely stores and manages RetinoScan data while providing a referral pathway to seamlessly co-ordinate patient care between health providers.
Health professionals and patients can access the TeleEye MD platform where the patient journey is clearly depicted via the integration of RetinoScan reports, RetinoScan Advanced monitoring services and referral pathways, to optimize health outcomes.
Your security and privacy are at the forefront of our technology. We employ industry standard AES256 encryption with a secure SSL/TLS layer. Data is hosted in the country of client registration in compliance with HIPAA and GDPR protection standards, to ensure secure housing and access.